Andrew Hider
President and Chief Executive Officer
Executive
1 yr
5 reports
Leadership change Andrew Hider became President and CEO · DEF 14A, Mar 2026
Baxter International Inc. ·BAX
CEO-led enterprise with interim CFO during post-divestiture transition
Health Care · Fortune #288 · Hybrid structure · 38K employees · Deerfield, Illinois
View as of:
4
CEO span
↓ tighter than peers (avg 10)
3
Avg span
moderate
2
Max depth
2 levels
3 yr
Avg tenure
↓ 3.0yr from FY2024
50%
Internal hires
near industry avg
Consolidated financials FY2025 · period end 2025-12-31 · 10-K
Revenue
$11.2B
Operating income
$-308000000
Net income
$-957000000
Total assets
$20.1B
Shares out
514M
Sourced from Baxter International Inc. DEF 14A · filed 2026-03-23 ↗ View on SEC
Interactive org chart
Baxter International Inc. organizational chart
Explore the executive structure, reporting layers, and scenario-ready operating model from public filings.
Open editable chart
Take this model into your AI workspace Use AI to reason through the model, then bring the scenario back into Creately Atlas.
Choose a prompt, then open an AI app and paste.
Download the CSV data instead
Baxter operates a CEO-centric enterprise structure following major leadership changes, including an interim CFO appointment. This page details the current executive team, reporting lines, recent transitions, and how Baxter’s structure compares with healthcare peers.
What to model
Use the chart to test org decisions, not just view reporting lines
Start with the public baseline, then use the scenario views and source-backed changes to ask what happens when leadership, span, or team ownership shifts.
Latest signal Joel Grade departed as Executive Vice President and CFO
CFO role ceased March 16, 2026; transitioned to advisory role through April 2026.
Source · See change logScenario views in the chart
- Appoint Permanent CFO Hire a permanent CFO to replace the interim role and stabilize financial leadership.
- Reinstate COO Role Add a COO to reduce CEO span of control and strengthen operations execution.
Atlas work this supports
- Connect Workday or UKG Get these analytics for YOUR org — tenure, span of control, headcount, automatically from your HRIS.
- Connect Salesforce Map your target accounts like this. Import contacts, visualize decision chains, plan multi-threading.
- Plan a Reorg Use this as a starting point. Model scenarios, compare structures, present options to your board.
The people
Who's running this
6 executives identified as Named Executive Officers in the most recent SEC proxy. Bar length scales with tenure.
internal
Reazur Rasul
Executive Vice President and Group President, Healthcare Systems & Technologies
Healthcare Systems & Technologies
6 yr
0 reports
internal
Cecilia Soriano
Group President, Infusion Therapies & Technologies and Pharmaceuticals
Infusion & Pharmaceuticals
2 yr
0 reports
internal
Anita Zielinski
Interim Chief Financial Officer
Finance
0 yr
0 reports
David Rosenbloom
Executive Vice President and General Counsel
Legal
4 yr
0 reports
Heather Knight
Former Executive Vice President and Chief Operating Officer
Operations
2 yr
0 reports
The pay
Executive compensation
From the most recent DEF 14A Summary Compensation Table. 1 named executive officers disclosed. Bar length scales with total compensation.
Andrew Hider $29.8M
- Base salary
- $499K
- Bonus
- $1.00M
- Stock awards
- $23.13M
- Option awards
- $3.19M
- Non-equity incentive
- $820K
- Other
- $1.17M
- Fiscal year
- FY2025
- Source
- SEC DEF 14A ↗
The skin in the game
Beneficial ownership
Insider stock holdings and the company's ownership requirements for executives and directors. Disclosed in the most recent DEF 14A.
Stock ownership requirements
Stock ownership guidelines were amended in 2025 to add retention requirements.
The businesses
How Baxter International Inc. divides the work
3 divisions report into the group CEO. Tile size scales with estimated headcount.
Finance
1K employees
Interim CFO (Anita Zielinski)
Manages financial reporting, capital allocation, controls and investor reporting.
Legal & Compliance
400 employees
EVP & General Counsel (David Rosenbloom)
Oversees legal affairs, compliance, ethics and corporate governance.
Healthcare Systems & Technologies
12K employees
Group President (Reazur Rasul)
Provides connected care, devices and digital health technologies.
The thesis
Why this org is unusual
Baxter’s most distinctive structural feature is its CEO-led enterprise operating model during a leadership transition, with an interim CFO reporting directly to the CEO.
The structure reflects a simplified post–Kidney Care divestiture organization, concentrating authority at the top while maintaining strong group presidents over major therapy and technology segments. The absence of a permanent CFO and the recent COO departure have temporarily narrowed the executive bench.
- Interim CFO
- Recent COO departure
- Post-divestiture simplification
The comparison
How Baxter International Inc. stacks up
Compared with peers such as Medtronic and Becton Dickinson, Baxter currently operates with a leaner C-suite due to recent departures and interim appointments. Peers generally maintain stable CFO and COO roles, whereas Baxter is consolidating oversight under the CEO. This creates faster decision-making but increases …
C-suite size
Reporting depth
Baxter International Inc.
2 levels
Medtronic
5 levels
Becton Dickinson
5 levels
Abbott Laboratories
6 levels
5 levels
Avg C-suite tenure
Baxter International Inc.
3 yr
Medtronic
6 yr
Becton Dickinson
7 yr
Abbott Laboratories
8 yr
Has COO / Has CAIO
Baxter International Inc. ✓ COO — no CAIO
Medtronic ✓ COO — no CAIO
Becton Dickinson ✓ COO — no CAIO
Abbott Laboratories ✓ COO — no CAIO
Current signals
What changed recently
The most consequential change was the March 2026 CFO transition, with Joel Grade departing and Anita Zielinski appointed interim CFO.
Leadership Timeline
Year-over-year executive structure based on SEC proxy and annual filings.
FY2025
DEF 14A filed 2026-03-23
- CEO
- Andrew Hider
- CEO span
- 5
- C-suite
- 7
- Avg tenure
- 4 yr
Leadership reflects transition year following Kidney Care divestiture.
Named executive officers (5)
- Andrew Hider - President and CEO since 2025
- Joel Grade - CFO since 2023
- Reazur Rasul - Group President since 2019
- David Rosenbloom - General Counsel since 2022
- Cecilia Soriano - Group President since 2023
FY2024
DEF 14A filed 2025-03-25
- CEO
- Jos E. Almeida
- CEO span
- 6
- C-suite
- 8
- Avg tenure
- 6 yr
Almeida served as CEO prior to 2025 transition.
FY2023
DEF 14A filed 2024-03-26
- CEO
- Jos E. Almeida
- CEO span
- 6
- C-suite
- 8
- Avg tenure
- 7 yr
Stable pre-divestiture leadership structure.
Year-over-year changes
2025 marked a CEO transition and a leaner executive team.
- CEO span: 6 → 5
- C-suite size: 8 → 7
- Avg tenure: 6 → 4 yr
- new Andrew Hider - President and CEO (DEF 14A, Mar 2026)
- departed Jos E. Almeida - CEO (was Chair, President and CEO) (DEF 14A, Mar 2026)
The board
Board of directors
2 directors. 2 of 2 independent (100%). Source: most recent DEF 14A.
Brent Shafer
Chair Independent
Non-Executive Chair, Baxter International Inc.
William A. Ampofo II
Independent
Frequently Asked Questions
Who is the CEO of Baxter International?
Andrew Hider has served as President and CEO since August 19, 2025.
What type of organizational structure does Baxter International use?
Baxter uses a hybrid enterprise structure combining functional leadership with major operating segments.
How many direct reports does Baxter International's CEO have?
The CEO currently has four primary direct reports.
How has Baxter International's leadership changed recently?
Recent changes include the departure of CFO Joel Grade and the appointment of Anita Zielinski as interim CFO in March 2026.
Does Baxter International have a COO?
No, Baxter does not currently have a COO following Heather Knight’s departure in October 2025.
Sources
- 8-K Filing, Mar 2026
- DEF 14A, Mar 2026
- SEC EDGAR: Baxter International Inc. DEF 14A Proxy Statement
- SEC EDGAR: Baxter International Inc. 10-K Annual Report
Reference
Cite this page
If you reference this page in research, analysis, or news writing, use one of the formats below. Citation includes the SEC filing source where applicable.
APA 7th
Creately. (2026). Baxter International Inc. organizational structure. Creately. Retrieved , from https://creately.com/org-chart/fortune-500/baxter-international/MLA 9th
"Baxter International Inc. Organizational Structure." Creately, April 1, 2026, https://creately.com/org-chart/fortune-500/baxter-international/. Accessed .Chicago 17
Creately. "Baxter International Inc. Organizational Structure." Last modified April 1, 2026. https://creately.com/org-chart/fortune-500/baxter-international/.Original SEC source View on SEC ↗
Baxter International Inc.. DEF 14A. Filed 2026-03-23. U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/10456/000162828026020330/bax-20260320.htmPermanent URL: https://creately.com/org-chart/fortune-500/baxter-international/ · last updated 2026-04-01